DNMT3B regulates the miR-29b/PTHLH/CDK4/RUNX2 axis by inducing hypermethylation of specific CpG sites in the miR-29b promoter region, preventing chondrocyte loss due to osteoarthritis (Dou, et al., 2020). Here, DNMT3B is linked to osteoarthritis.